Cannabinoid Medicine Observational Study (CMOS): Observation of cannabinoid prescribing and dosage patterns in Australian clinical practice

Not Applicable

• Conditions: Cancer pain; Anxiety disorders; Palliative care; Epilepsy; Chronic non-cancer pain; Sleep disorders; Multiple Sclerosis; Gastrointestinal disorders; Chemotherapy-induced nausea and vomiting (CINV); Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12620000718943
• Lead Sponsor: Applied Cannabis Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-02
• Last Update Posted: 6 July 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

Seeking or already receiving medicinal cannabis therapy and deemed eligible for medicinal cannabis prescription by their treating physician.

Exclusion Criteria

1.Any severe cognitive, intellectual disability, medical or psychiatric condition that impairs the participant’s ability to provide informed consent
2.Females who are pregnant or breastfeeding.

Study & Design

• Study Type: Observational
• Study Design: Not specified